Las Vegas, NV -- (SBWIRE) -- 01/10/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: NQ Mobile Inc (ADR)(NYSE:NQ), Inovio Pharmaceuticals Inc(NYSEMKT:INO), Dynavax Technologies Corporation(NASDAQ:DVAX), Integrated Device Technology Inc(NASDAQ:IDTI)
NQ Mobile Inc (ADR)(NYSE:NQ) was a volume gainer of 3.09 million shares and the average volume of the stock remained 3.45 million shares. The stock opened the session at $14.35 and finished at the end of the day at $13.93 and the stock plunged -0.64%.The market capitalization of the stock remained 672.19 million. NQ Mobile Inc. provides mobile Internet services in the areas of mobile security, privacy, productivity, personalized cloud, and family protection. It operates through two segments, Consumer and Enterprise. The company was formerly known as NetQin Mobile Inc. and changed its name to NQ Mobile Inc. in April 2012.
Has NQ Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Inovio Pharmaceuticals Inc(NYSEMKT:INO) exchanged 3.03 million shares and the average volume remained 5.20 million shares. The stock closed the session at $2.46 with the drop of -0.81%. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010.
Why Should Investors Buy INO After the Recent Fall? Just Go Here and Find Out
Dynavax Technologies Corporation(NASDAQ:DVAX) enhanced 2.11% and its closing price was $1.94. The volume of the stock was 2.99 million shares and the average volume remained 5.07 million shares. The market capitalization of the stock remained 509.49 million. The beta of the stock remained 2.83. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996.
Why Should Investors Buy DVAX After The Recent Gain? Just Go Here and Find Out
Integrated Device Technology Inc(NASDAQ:IDTI) exchanged 2.97 million shares in the previous trading session, and its average trading remained 1.57 million shares. IDTI advanced 2.62% and it closed the trading at $10.18. The market capitalization of the stock remained 1.54 billion. Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of mixed signal semiconductor solutions for the communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer.
For How Long IDTI’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)